Women who took a probiotic supplement for bothersome vaginal odor and symptoms such as irritation and painful urination reported substantial improvements within 2 weeks, according to study findings presented at the NAMS Annual Meeting.
/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") will present 52-week results from the Phase 3 SKYLIGHT.
Medication can play an essential role in breast cancer prevention, Holly J. Pederson, MD, director of medical breast services at the Cleveland Clinic, said during the NAMS Annual Meeting.
“My objectives. are to identify women who will benefit most from risk-reducing medications, to recognize the importance of comorbid conditions and the timing of therapy and to develop strategies for